Applied Therapeutics Inc (APLT) Live Share Price, Invest From India

Applied Therapeutics Inc Stock Performance

as on February 3, 2026 at 7:59 am IST

Day's Low
$0.10
Day's Price Range
$0.11
$0.11
9.09%
Downside
52 Week's Low
52 Week's High
$0.09
52-Week Price Range
$1.50
$0.11
18.18%
Downside
1263.64%
Upside

Applied Therapeutics Inc share price movements today

Previous Close: $0.10
Open: $0.10
Volume: 3.4M
Day's Low - High: $0.10 - $0.11
52 Week Low - High: $0.09 - $1.50

Applied Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Applied Therapeutics Inc Stock Fundamentals & Key Indicators

Check Applied Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Applied Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Applied Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Applied Therapeutics Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	95.3%	1246.03	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	120.19%	33.56	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	53.89%	18.28	32.13%

Analyst Recommendation on Applied Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Applied Therapeutics Inc. Average target price of $0.25

Applied Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Applied Therapeutics Inc.

What analysts predicted

56%UPSIDE

Target Price

$0.25

Current Price

$0.11

Analyzed by

11 Analysts

Target

$0.25

Applied Therapeutics Inc target price $0.25, a slight upside of 56% compared to current price of $0.11. According to 11 analysts rating.

Applied Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	0	0	0	-	0	-	1
Gross Profit	-11	0	-15	-12	0	0	-	-7	-9	1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-29	-42	-37	-83	2	-68	44	-21	-21	-18
Net Profit Margin	0.00%	0.00%	5649.03%	-44177.89%	2012.50%	-56222.13%	0.00%	2182500.00%	0.00%	-1899.00%

Applied Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	10	9	0
Gross Profit	-	-	0	0	0	0	-43	-48
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-4	-16	-45	-93	-104	-82	-119	-105
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-774.00%	-1198.47%	-23214.07%

Global Institutional Holdings in Applied Therapeutics Inc

Funds	Holdings
T. Rowe Price Investment Management,Inc.	12.97%
Knoll Capital Management LP	5.42%
Simplify Asset Management Inc.	3.12%
Propel Bio Management LLC	7.84%
BlackRock Inc	3.62%

See all

Applied Therapeutics Inc News & Key Events

Insights on Applied Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 131.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 121.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, APLT stock has moved down by -12.7%

About Applied Therapeutics Inc

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the development of drug candidates against validated molecular targets in rare diseases. The Company’s lead drug candidate, govorestat, is a central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including classic galactosemia, sorbitol dehydrogenase (SORD) deficiency and phosphomannomutase 2 (PMM2)-congenital disorder glycosylation (CDG). The Company is also developing AT-001, an investigational, ARI developed as an oral therapy for the treatment of diabetic cardiomyopathy (DbCM). It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type II diabetes. The Company’s pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, and has demonstrated strong retinal penetrance, for the treatment of diabetic retinopathy (DR).

Organisation	Applied Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Applied Therapeutics Inc share price today?

Applied Therapeutics Inc share price today is $0.11 as on February 3, 2026 at 2:29 am IST at the close of the market. Applied Therapeutics Inc share today touched a day high of $0.11 and a low of $0.1.

What is the 52 week high and 52 week low for Applied Therapeutics Inc share?

Applied Therapeutics Inc share touched a 52 week high of $1.5 on October 21, 2025 and a 52 week low of $0.09 on January 12, 2026. Applied Therapeutics Inc stock price today i.e. February 3, 2026 at 2:29 am IST is closed at $0.11,which is 92.67% down from its 52 week high and 22.22% up from its 52 week low.

How to invest in Applied Therapeutics Inc Stock (APLT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Applied Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Applied Therapeutics Inc Shares that will get you 13.6364 shares as per Applied Therapeutics Inc share price of $0.11 per share as on February 3, 2026 at 2:29 am IST.

What is the minimum amount required to buy Applied Therapeutics Inc Stock (APLT) from India?

Indian investors can start investing in Applied Therapeutics Inc (APLT) shares with as little as ₹90.637 or $1 (as of February 12, 2026 at 8:28 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹906.37 in Applied Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on February 12, 2026 at 8:28 am IST). Based on Applied Therapeutics Inc share’s latest price of $0.11 as on February 3, 2026 at 2:29 am IST, you will get 90.9091 shares of Applied Therapeutics Inc. Learn more about fractional shares .